Xcout IntelSign inSubscribe

Cardurion Pharmaceuticals, LLC

TherapeuticsBurlington, United States

Cardurion Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Burlington, Massachusetts, focused on discovering and developing novel therapeutics for cardiovascular diseases.

Subscribe to see Cardurion Pharmaceuticals, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Cardurion Pharmaceuticals, LLC at a glance

Cardurion Pharmaceuticals, LLC is a therapeutics company headquartered in Burlington, United States. It has raised at least $431.7M across the 5 funding rounds on record. Its most recent funding round, Series B, raised $260.4M in July 2024. Xcout tracks 13 named people at Cardurion Pharmaceuticals, LLC, including Peter S. Lawrence (President and CEO).

As of 16 November 2026. Source: Xcout Intel.

Industry
Therapeutics
Headquarters
Burlington, United States
Raised, rounds on record
$431.7M

Cardurion Pharmaceuticals, LLC leadership

  • Peter S. LawrencePresident and CEO
  • Charlotte NewmanChief Business & Operating Officer
  • Howard K. SurksChief Medical and Scientific Officer
  • Karen LewisChief People Officer
  • Ron RenaudChairman
  • Michael E. MendelsohnFounder and Chief Strategy Officer

7 more named people on record for Cardurion Pharmaceuticals, LLC, with roles, board committees and tenure — see the full roster →

Cardurion Pharmaceuticals, LLC funding rounds

At least $431.7M raised across the 5 rounds on record. Every round on record:

DateRoundAmountInvestors
Series B$260.4M12 named
SEC Form D filing$17.5M—
SEC Form D filing$128.1M—
SEC Form D filing$10M—
SEC Form D filing$15.7M—

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Investors

Cardurion Pharmaceuticals, LLC competitors

A few of Cardurion Pharmaceuticals, LLC's closest competitors — see the full list of competitors and alternatives →

Cyclerion Therapeutics, Inc.CYCN · BiotechCambridge, MA, United States
71% matchPublic

Cyclerion Therapeutics, Inc. operates as a biopharmaceutical company in the clinical development phase, concentrating on the discovery, advancement, and commercialization of therapeutic agents for debilitating central nervous system (CNS) disorders. Their leading experimental compound, CY6463, is a soluble guanylate cyclase (sGC) stimulator designed to cross the blood-brain barrier. It is presently in Phase IIa clinical assessments for managing mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), as well as Alzheimer's disease with vascular involvement. Concurrently, CY6463 is undergoing Phase 1 trials for treating schizophrenia in adult populations. The company's research portfolio also features other promising candidates: Praliciguat, an orally administered systemic sGC stimulator, is in Phase II studies targeting resistant hypertension and diabetic nephropathy. Olinciguat, another sGC stimulator designed for oral intake with a vascular focus, is progressing through Phase II trials for sickle cell disease. Moreover, CY3018 is under development to address a range of CNS ailments. Cyclerion holds a licensing agreement with Akebia Therapeutics, Inc., covering the entire lifecycle from development and manufacturing to medical affairs and commercialization for certain pharmaceutical compounds and related products. The company was founded in 2018 and has its principal place of business in Cambridge, Massachusetts.

Market cap$15.7M
Employees1
Cyclerion Therapeutics, Inc. competitors & alternatives →

Get Cardurion Pharmaceuticals, LLC's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Something wrong or missing about Cardurion Pharmaceuticals, LLC? Suggest a correction · Work at Cardurion Pharmaceuticals, LLC? Claim this profile

Is this your company? Add the Xcout Intel badge to your website

Free, for any company on Xcout Intel. It links visitors to this profile.

Cardurion Pharmaceuticals, LLC on Xcout Intel

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Cardurion Pharmaceuticals, LLC — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Cardurion Pharmaceuticals, LLC in Xcout Intel

  • 13 named people with titles, LinkedIn and board committees
  • 5 funding rounds with the investors in each, and who they co-invest with
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →